- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The Icelandic founder mutation BRCA2 999del5: analysis of expression ; volume:6 ; number:4 ; day:7 ; month:4 ; year:2004 ; pages:1-7 ; date:8.2004
Breast cancer research ; 6, Heft 4 (7.4.2004), 1-7, 8.2004
- Urheber
-
Mikaelsdottir, Evgenia K.
- Beteiligte Personen und Organisationen
-
Valgeirsdottir, Sigridur
Eyfjord, Jorunn E.
Rafnar, Thorunn
SpringerLink (Online service)
- DOI
-
10.1186/bcr785
- URN
-
urn:nbn:de:1111-2016032354150
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mikaelsdottir, Evgenia K.
- Valgeirsdottir, Sigridur
- Eyfjord, Jorunn E.
- Rafnar, Thorunn
- SpringerLink (Online service)
Ähnliche Objekte (12)
A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population
A BRCA2 germline mutation and high expression of immune checkpoints in a TNBC patient
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
BRCA2 germline mutation carrier with five malignancies: a case report
The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Haplotype analysis suggest that the MLH1 c.2059C > T mutation is a Swedish founder mutation
PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population
A BRCA2 germline mutation and high expression of immune checkpoints in a TNBC patient
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
BRCA2 germline mutation carrier with five malignancies: a case report
The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Haplotype analysis suggest that the MLH1 c.2059C > T mutation is a Swedish founder mutation
PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population
A BRCA2 germline mutation and high expression of immune checkpoints in a TNBC patient
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
BRCA2 germline mutation carrier with five malignancies: a case report
The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Haplotype analysis suggest that the MLH1 c.2059C > T mutation is a Swedish founder mutation
PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan